Background: Reference intervals (RIs) are important for interpretation of laboratory results. Neuron-specific enolase (NSE) can be utilized to aid the diagnosis of various tumors. However, while red blood cells contain NSE αγ-isozymes, unrecognized slight hemolysis will result in increasing of NSE levels in serum. The aim of this study was to correct the NSE RIs from healthcare individuals results which may have unidentified microhemolysis.
| MATERIAL S AND ME THODS

| Study population
| Quantitation of NSE in serum
Fasting blood samples were drawn from healthcare individuals in the morning and transported to our laboratory within 3 hours after phlebotomizing. After centrifuging at 1600 g for 5 minutes, serum was separated and analyzed automatically. NSE test was measured by Roche Cobas e 601 electrochemiluminescence analyzer system and corresponding reagents. The parameters of analyzer system were set as follows: linear range was 0.05 ~ 370 ng/mL, with the analytical sensitivity for <0.05 ng/mL.
| Define of serum NSE reference interval
According to CLSI C28-A3 on how to establish a reference interval by Clinical and Laboratory Standard Institute (CLSI), 11 the reference interval should be built on samples from healthy population according to appropriate inclusive and exclusive criteria. Reference interval is an interval between the reference upper limit and lower limit. It is designated as the interval between a certain percentages (generally 95%) of values of the health population (usually a reference group) fall into. For most researches, the 2.5th percentile and 97.5th percentile are used as the lower limit and upper limit defining the reference interval. In many cases, only one side of the range has the clinical significance, which is usually the upper limit (the 97.5th percentile). As for the reference interval of NSE, with no clinical significance of the lower limit, the 97.5th percentile as the upper limit was used.
| Quantitation of free hemoglobin in serum
Measurement of free hemoglobin (fHb) in serum was performed with o-tolidine test. The mechanism is that the ferroheme in hemoglobin has similar activity with peroxidase, which can oxidize benzidine to present green color initially and then purple color. The concentration of fHb can be analyzed using UV spectrophotometer and a reference sample of already known fHb concentration. 12
| Statistical analyses
STATA software 12.0 was used for all statistical analysis. For prospective analyses (dependent samples), quantitative variables were compared using ANOVA. Quantitative variables were compared between two groups of independent samples using Mann-Whitney test for variables with non-normal distribution.
| RE SULTS
| Study population summary
In this period, a total of 21 354 healthy individuals came to hospital physical examination center of First Affiliated Hospital of Nanjing Medical University for healthcare examination and required NSE test. According to the previous excluded criterion, individuals who do not meet the requirements will be excluded. Consequently, 15 047 healthy individuals were included, with 8374 male individuals (age range: 14-75 years) and 6673 female individuals (age range: 15-77 years).
| Reference intervals
Previous studies show that there was no statistical difference in NSE reference interval between sex and age. 13 Therefore, the NSE reference intervals are not stratified according to the sex and age in this study. Considering the lower limit of NSE reference interval has no clinical significance, the 97.5th percentile upper limit as the reference interval was used. The reference interval of NSE from this study is 0-18.9 ng/mL. However, the reference interval of NSE is 0-16.3 ng/mL which is provided by the manufacturer and validated by our laboratory. The range of reference interval, which was established according to the physical examination center is higher than our previous transferring and validation reference interval. The possible reason for the reference interval widening is the unrecognized microhemolysis in the serum of healthcare individuals.
| Comparison between the NSE retests result and the initial result in healthcare individuals
While 0-16.3 ng/mL as RIs of NSE is used, the results from 16.3 to 18.9 ng/mL will be considered slightly elevated, wrong clinical decisions may be implemented. In order to validate the possible false high level in this population with an NSE level between 16.3 and 18.9 ng/mL, 74 volunteers from this population were randomly chosen. Repeated blood sampling by highly skilled technicians to ensure successful sampling process was carried out. As showed in Table 1 , an NSE retest level <16.3 ng/mL was seen in 63 patients. Only 11 patients had NSE levels higher than the reference interval, the ratio of higher NSE level drop to normal is 85.1% (63/74). As NSE distribution from 74 volunteers of initial and retest results are non-normal distribution by ANOVA, Mann-Whitney analysis is used to compare between the two groups. The retest results were significantly lower than the initial results (P = .00).
| Serum free hemoglobin measurement
The fHb levels in the initial serum and the retest serum of 22 healthy individuals randomly chosen from the 74 individuals were measured.
As fHb distribution from these healthy individuals of initial and retest results are non-normal distribution by ANOVA, Mann-Whitney analysis is used to compare between the two groups. As shown in Table 2 , the media of fHb concentration were 58 and 30 mg/L, respectively, marking a statistically significant higher fHb level in the initial serum than the retest serum (P = .00), which indicated slight hemolysis is a possible cause for the initially high NSE levels. As a preanalytic factor that may be neglected, microhemolysis may have affected the establishment of our reference interval.
| D ISCUSS I ON
Herein, we describe the correction of NSE reference intervals derived from healthcare individual samples. The NSE reference interval established in our study differs from the previous study. 14 The main reason is that the reference interval of previous study is established according to the strict rules of C28-A3, but in our research, the data derived from healthcare individuals may include unrecognized slight hemolysis in the serum.
It seems that the reference interval we defined was not accurate on account of not strictly referring to the exclude criterion of C28-A3 guideline. However, because of some tests which could be interfered by conditions we cannot identify, the preanalytic factors may be taken into account in the process of defining reference intervals.
Moreover, there are several studies that have attempted to derive reference values from patient samples. 10, 15 Therefore, the reference interval established by our study did take into account the possibility of slight hemolysis in some specimens. The reference interval we obtain is wider than the manufacturer provided. This further confirms that there may be unrecognized hemolysis in the specimens that we choose.
As is well known, hemolysis blood sample may affect the measurement of many tests, such as serum potassium, NSE and lactate dehydrogenase (LDH), etc 16 The hemolytic samples can be regarded as unqualified specimens and rejected. The visible hemolysis samples can be identified by machine or naked eyes easily, but if slight hemolysis could not be identified, erroneous results may lead to wrong clinical decisions.
In the previous studies, many laboratory scientists have been concerned about the impact of hemolysis on NSE results and try to In order to validate our possible speculation, we chose 74 volunteers of this population with an NSE level between 16.3 and 18.9 ng/ mL and draw blood samples by skilled technicians to avoid the hemolysis in drawing blood process. The second NSE results below 16.3 ng/mL were showed in 63 patients; this further confirmed that the first results, which will decrease in second results, were affected by hemolysis. Moreover, we measured the fHb levels in the initial serum and the second serum of 22 healthy individuals randomly chosen from the 74 individuals. It is showed that slight hemolysis as a preanalytic factor may be neglected, which may be taken into consideration on the progress in the NSE reference interval definition.
In summary, by correction of the NSE reference interval for the slight hemolysis in the serum of which may lead to clinical wrong decision, we redefine the NSE reference interval which the recruitment samples may involve the unrecognized slight hemolysis according to the C28-A3 guideline. This correction reference interval may have some shortcomings such as that the reference interval becomes wider, which may cause some patients to be unable to diagnose. The other is that the reference interval is only from a single-center study.
The multi-center study will be taken into consideration in our future research. However, its advantages are also obvious. The correction may be expected to decrease the abnormal NSE test which may minimize the next healthcare costs. The reference interval is derived from the healthy individuals of our hospital, ongoing working at our hospital, assessing the clinical utility of this redefined reference interval in the prediction of neurological diseases.
